Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins on immune cells may help treat alopecia areata.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Alopecia areata causes unpredictable hair loss and is hard to treat.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

The treatment didn't work for the woman's hair loss and skin darkening.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The phyto-caffeine shampoo reduced hair loss and improved hair strength in women with hair thinning.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Cancer treatments often cause skin, nail, and hair problems.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

A man regrew hair after using a 2% fluorouracil treatment on his scalp.